Easyhaler® product family
Product info | 19/12/2022EASYHALER®: A CARBON NEUTRAL INHALER RANGE1
The Easyhaler® product family provides a selection of treatment options for both asthma and COPD patients available in a dry powder inhaler form:
Inhaled Corticosteroids
Short acting beta agonist
Long acting beta agonist
Inhaled corticosteroid + long acting beta agonist
COPD = Chronic obstructive pulmonary disease, ICS = Inhaled corticosteroid, SABA = Short acting beta agonist, LABA = Long acting beta agonist, ICS + LABA = Inhaled corticosteroid + long acting beta agonist, FEV1 = Forced expiratory volume in the first second
References:
1. Carbon Neutral Certificate for Easyhaler product range. Orion Pharma. Data on file.
Adverse events should be reported. Reporting forms and information
can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.
![]() |
||||||
PRESENTATIONS: AGE: STRENGTHS (ACTUATIONS), PRICE: INDICATION: patients not adequately controlled with or patients already adequately controlled |
|
COPD: (50/500mcg only): CONTRAINDICATIONS: UNDESIRABLE EFFECTS: ADVERSE EVENTS: Prescribers should consult the SmPC in relation to other side effects. |
||||
|
||||||
![]() |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PRESENTATIONS: AGE: STRENGTHS (ACTUATIONS), PRICE: INDICATION: |
|
CONTRAINDICATIONS: UNDESIRABLE EFFECTS: ADVERSE EVENTS: Prescribers should consult the SmPC in relation to other side effects. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
October 2025 / RESP-330bbc(6)